Tata Health (01255) announced that the company received a letter from the Stock Exchange of Hong Kong on June 27, 2024. In the letter, the Exchange gave instructions for resuming trading, including publishing all unaudited financial performance required by listing rules and handling any audit revisions, demonstrating compliance with Rule 13.24, and disclosing all important information to the market for shareholders and potential investors to evaluate the company's condition.
Tata Health (01255) announced that it received a letter from the Stock Exchange of Hong Kong on June 27, 2024. The letter included instructions for resuming trading, including publishing all unaudited financial performance required by listing rules and handling any audit revisions, demonstrating compliance with Rule 13.24, and disclosing all important information to the market for shareholders and potential investors to evaluate the company's condition.
Under Listing Rule 6.01A, the Stock Exchange of Hong Kong may cancel the listing status of any security that has been suspended from trading for 18 consecutive months. For the company, the 18-month deadline will expire on October 1, 2025. The company's shares continue to be suspended from trading.